Account
Articles
12.01.2026
If You’re a Market Access Lead in 2026: What W...

Have you ever wondered what separates the organisations that consistently secure unhindere...

Read more
Articles
03.12.2025
Market Access & Pricing Trends for 2026

The Top Market Access Trends for 2026 The market access trends 2026 are being shaped by increasing g...

Read more
Articles
26.11.2025
2025 Market Access Check-In: Evaluating the Impact...

2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...

Read more
Articles
03.11.2025
Designing Payer-Ready Trials in 2025: Five Decisio...

Clinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...

Read more
Articles
21.10.2025
Comparator Choice: The Question That Defines Marke...

Every payer ultimately asks the same question: “Compared with what?” This single question shapes...

Read more
Articles
13.10.2025
Surrogates Under Scrutiny: Proving the Link to Out...

Surrogate Endpoints in HTA Decision-Making The need to stay ahead of competitors and offset losses f...

Read more
Articles
08.10.2025
Orchestrating Evidence Needs: Overcoming Regulator...

Optimising evidence generation in trial design, while navigating regulatory and local payer requirem...

Read more
Articles
01.10.2025
MFN Drug Pricing Proposal: What It Could Mean for ...

Negotiations between the Trump administration and pharmaceutical companies on lowering U.S...

Read more
Articles
29.09.2025
Your 5-step ATMP pricing playbook for launch succe...

Advanced Therapy Medicinal Products (ATMPs) are offering transformative, and often life-saving, trea...

Read more
Articles
22.09.2025
ATMP Pricing in Practice: Success & Cautionary...

Advanced Therapy Medicinal Products (ATMPs) are leading in healthcare innovation, providing potentia...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.